Abnormal glycosylation of CA125 promotes tumor–mesothelial adhesion by providing binding sites for ovarian cancer cells to interact with multiple adhesion molecules on the mesothelial cell surface [31, 32]. The gene discussed is MUC16; the disease is neoplasm.